Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells

IUBMB Life

Volumn 64, Issue 9, 2012, Pages 775-782

  Zhou, Cheng Fu ^a   Li, Xue Bing ^b   Sun, Heng ^b   Zhang, Bo ^a   Han, Yu Song ^a   Jiang, Yi ^a   Zhuang, Qiu Lin ^a   Fang, Jing ^b   Wu, Guo Hao ^a  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

cell proliferation; cellular glucose metabolism; colorectal cancer; migration; protein expression; protein function; pyruvate kinase

Indexed keywords

PYRUVATE KINASE; PYRUVATE KINASE ISOENZYME M 2; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GLYCOLYSIS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PYRUVATE KINASE; TUMOR BURDEN; UP-REGULATION;

EID: 84865321569     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1066     Document Type: Article

References (46)

1. Ortega, A. D., Sánchez-Aragó, M., Giner-Sánchez, D., Sánchez-Cenizo, L., Willers, I., and, Cuezva, J. M., (2009) Glucose avidity of carcinomas. Cancer Lett. 276, 125-135.
2. Gupta, V., and, Bamezai, R. N., (2010) Human pyruvate kinase M2: a multifunctional protein. Protein Sci. 11, 2031-2044.
3. Gillies, R. J., and, Gatenby, R. A., (2007) Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? Bioenerg. Biomembr. 39, 251-257. (Pubitemid 47619378)
4. Goetze, K., Walenta, S., Ksiazkiewicz, M., Kunz-Schughart, L. A., and, Mueller-Klieser, W., (2011) Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int. J. Oncol. 39, 453-463.
5. Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., Stern, A. M., Mandinova, A., Schreiber, S. L., and, Lee, S. W., (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 13, 231-234.
6. Grüning, N. M., and, Ralser, M., (2011) Cancer: sacrifice for survival. Nature 7, 190-191.
7. Warburg, O., (1956) On the origin of cancer cells. Science 123, 309-314.
8. Altenberg, B., and, Greulich, K. O., (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020. (Pubitemid 39469126)
9. Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., Loda, M., Lane, H. A., and, Sellers, W. R., (2004) mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10, 594-601. (Pubitemid 38796850)
10. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., and, Cantley, L. C., (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233. (Pubitemid 351380249)
11. Jurica, M. S., Mesecar, A., Heath, P. J., Shi, W., Nowak, T., and, Stoddard, B. L., (1998) The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure 6, 195-210. (Pubitemid 28153883)
12. Mazurek, S., Boschek, C. B., Hugo, F., and, Eigenbrodt, E., (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 15, 300-308. (Pubitemid 41058775)
13. Zwerschke, W., and, Jansen-Dürr, P., (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv. Cancer Res. 78, 1-29.
14. Christofk, H. R., Vander Heiden, M. G., and, Wu, N., (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181-186. (Pubitemid 351380242)
15. Hitosugi, T., Kang, S., Vander Heiden, M. G., Chung, T. W., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G. Z., Xie, J., Gu, T. L., Polakiewicz, R. D., Roesel, J. L., Boggon, T. J., Khuri, F. R., Gilliland, D. G., Cantley, L. C., Kaufman, J., and, Chen, J., (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2, ra73.
16. Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., and, Jansen-Dürr, P., (1999) Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 96, 1291-1296. (Pubitemid 29098444)
17. Mazurek, S., Zwerschke, W., Jansen-Dürr, P., and, Eigenbrodt, E., (2001) Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene 20, 6891-6898. (Pubitemid 33052178)
18. Kosugi, M., Ahmad, R., Alam, M., Uchida, Y., and, Kufe, D., (2011) MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells. PLoS One 6, e28234.
19. Vlashi, E., Lagadec, C., Vergnes, L., Matsutani, T., Masui, K., Poulou, M., Popescu, R., Della Donna, L., Evers, P., Dekmezian, C., Reue, K., Christofk, H., Mischel, P. S., and, Pajonk, F., (2011) Metabolic state of glioma stem cells and nontumorigenic cells. Proc. Natl. Acad. Sci. USA 108, 16062-16067.
20. 2PK. J. Cancer Res. Clin. Oncol. 136, 219-225.
21. Jemal, A., Siegel, R., Xu, J., and, Ward, E., (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300.
22. Hyodo, I., Suzuki, H., Takahashi, K., Saito, Y., Tanaka, S., Chiu, H. M., Kim, N. K., Li, J., Lim, R., Villalon, A., and, Boku, N., (2010) Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group Report in 30th Asia-Pacific Cancer Conference. Jpn. J. Clin. Oncol. 40 (Suppl 1), i38-i43.
23. Adam, R., Haller, D. G., Poston, G., Raoul, J. L., Spano, J. P., Tabernero, J., and, Van Cutsem, E., (2010) Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer-an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009. Ann. Oncol. 21, 1579-1584.
24. Xue, J., Li, X. B., Jiao, S., Wei, Y., Wu, G. H., and, Fang, J., (2010) Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKβ independent of hydroxylase activity. Gastroenterology 138, 606-615.
25. Hu, X. W., Meng, D., and, Fang, J., (2008) Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 29, 2369-2376.
26. Spoden, G. A., Mazurek, S., Morandell, D., Bacher, N., Ausserlechner, M. J., Jansen-Dürr, P., Eigenbrodt, E., and, Zwerschke, W., (2008) Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation. Int. J. Cancer 123, 312-321. (Pubitemid 351842015)
27. Koss, K., Harrison, R. F., Gregory, J., Darnton, S. J., Anderson, M. R., and, Jankowski, J. A., (2004) The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia- adenocarcinoma sequence in Barrett's oesophagus. J. Clin. Pathol. 57, 1156-1159. (Pubitemid 39486520)
28. Bluemlein, K., Grüning, N. M., Feichtinger, R. G., Lehrach, H., Kofler, B., and, Ralser, M., (2011) No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2, 393-400.
29. Spoden, G. A., Rostek, U., Lechner, S., Mitterberger, M., Mazurek, S., and, Zwerschke, W., (2009) Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death-dependent on glucose supply. Exp. Cell Res. 315, 2765-2774.
30. Walenta, S., Schroeder, T., and, Mueller-Klieser, W., (2002) Metabolic mapping with bioluminescence: basic and clinical relevance. Biomol. Eng. 18, 249-262. (Pubitemid 34158559)
31. Wernicke, M., Pineiro, L. C., Caramutti, D., Dorn, V. G., Raffo, M. M., Guixa, H. G., Telenta, M., and, Morandi, A. A., (2003) Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod. Pathol. 16, 99-107. (Pubitemid 36245740)
32. Katayama, M., Sanzen, N., Funakoshi, A., and, Sekiguchi, K., (2003) Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res. 63, 222-229. (Pubitemid 36070443)
33. Yang, H. S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C. C., Tan, T. H., and, Colburn, N. H., (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell Biol. 26, 1297-1306. (Pubitemid 43202557)
34. Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., and, Mueller-Klieser, W., (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51, 349-353. (Pubitemid 32884281)
35. Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., and, Mueller-Klieser, W., (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916-921. (Pubitemid 30129526)
36. Koukourakis, M. I., Kontomanolis, E., GiatromanolakiSivridis, A., and, Liberis, V., (2009) Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol. Obstet. Invest. 67, 162-168.
37. Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., Frank, P. G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U. E., Sotgia, F., and, Lisanti, M. P., (2010) Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9, 3506-3514.
38. Yeluri, S., Madhok, B., Prasad, K. R., Quirke, P., and, Jayne, D. G., (2009) Cancer's craving for sugar: an opportunity for clinical exploitation. J. Cancer Res. Clin. Oncol. 135, 867-877.
39. Gillies, R. J., Robey, I., and, Gatenby, R. A., (2008) Causes and consequences of increased glucose metabolism of cancers. J. Nucl. Med. 49 (Suppl 2), 24S-42S. (Pubitemid 351948035)
40. Gatenby, R. A., and, Gillies, R. J., (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. 4, 891-899. (Pubitemid 39472955)
41. Goetze, K., Walenta, S., Ksiazkiewicz, M., Kunz-Schughart, L. A., and, Mueller-Klieser, W., (2011) Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int. J. Oncol. 39, 453-463.
42. Baumann, F., Leukel, P., Doerfelt, A., Beier, C. P., Dettmer, K., Oefner, P. J., Kastenberger, M., Kreutz, M., Nickl-Jockschat, T., Bogdahn, U., Bosserhoff, A. K., and, Hau, P., (2009) Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro. Oncol. 11, 368-380.
43. Beckert, S., Farrahi, F., Aslam, R. S., Scheuenstuhl, H., Königsrainer, A., Hussain, M. Z., and, Hunt, T. K., (2006) Lactate stimulates endothelial cell migration. Wound Repair Regen. 14, 321-324. (Pubitemid 43979262)
44. Végran, F., Boidot, R., Michiels, C., Sonveaux, P., and, Feron, O., (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71, 2550-2560.
45. Swietach, P., Vaughan-Jones, R. D., and, Harris, A. L., (2007) Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 26, 299-310. (Pubitemid 47101667)
46. Shi, H. S., Li, D., Zhang, J., Wang, Y. S., Yang, L., Zhang, H. L., Wang, X. H., Mu, B., Wang, W., Ma, Y., Guo, F. C., and, Wei, Y. Q., (2010) Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Sci. 101, 1447-1453.